Public company
VOLITIONRX LTD
VNRXCIK 0000093314
Price$0.19
1 year-97.5%
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score21
Connections with evidence4
VNRX · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Batchelor Ann-LouiseGroup Chief Marketing Officer | VNRXVOLITIONRX LTD Grant or award | A | — 12.0K sh | Oct 23, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 4, 2026
- ← Insider ofevidenceBatchelor Ann-LouiseGroup Chief Marketing Officer · Oct 23, 2026
- ← Insider ofevidenceForterre GaelChief Commercial Officer · Sep 30, 2026
- ← Insider ofevidenceMichel GaetanChief Operating Officer · Sep 30, 2026